$39.06
0.0050.01%
In chiusura: Nov 17, 4:00 PM EST
$39.63
0.571.46%
Post-mercato: 4:01 PM EST
Hemab Therapeutics Hldgs (COAG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 10, 2026 | $-0.58 | $-0.51 | -13.7 % |
| Q2 | Aug 11, 2026 | $-0.80 | $-0.78 | -2.56 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.51 | $-0.78 | — |
| Actual | $-0.58 | $-0.80 | $-23.98 |
| Surprise | -13.7% | -2.56% | — |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.56 | $-0.61 | $-0.70 | $-0.71 |
| Revenue | ||||
| Consensus | — | — | — | — |
